Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Annals of Surgical Oncology|February 25, 2015
FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer PatientsChenpu Xu, Qun Wei, Jufeng Guo, et al.Cell Death Discovery|February 23, 2023
Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on ItCong Chen, Qianwei Ye, Linbo Wang, et al.International Immunopharmacology|August 28, 2020
Oridonin inhibits 4T1 tumor growth by suppressing Treg differentiation via TGF-β receptorJufeng Guo, Tao Chen, Zeyu Ma, et al.Pharmacological Research|February 5, 2021
Schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammationZeyu Ma, Gang Xu, Yingying Shen, et al.Neoplasma|September 29, 2025
The mir-371a-373 cluster: A crucial miRNA cluster promotes the malignancy of gastric cancerZonglei Mao, Yi Pan, Jiaping Wu, et al.Journal of Advanced Research|January 27, 2026
A novel extracellular vesicle-engineered immunotherapy drug for Her2+ breast cancerXinliang Lu, Weiyi Yuan, Xianchang Zeng, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2014
Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancerQinchuan Wang, Jichun Zhou, Jufeng Guo, et al.Frontiers in Immunology|June 9, 2020
Th9 Cell Differentiation and Its Dual Effects in Tumor DevelopmentTao Chen, Jufeng Guo, Zhenhai Cai, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2025
A Novel tRF, HCETSR, Derived From tRNA-Glu/TTC, Inhibits HCC Malignancy by Regulating the SPBTN1-catenin Complex AxisTao Rui, Kangbei Zhu, Zonglei Mao, et al.Nature Communications|June 14, 2022
Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradationYingying Shen, Chaojie Lu, Zhengbo Song, et al.Pageof 4